Home Fashion FDA Adds Warning Label to Weight-Loss Drugs for Eye Condition

FDA Adds Warning Label to Weight-Loss Drugs for Eye Condition

FDA Adds Warning Label to Weight-Loss Drugs for Eye Condition

This post was originally published on this site.

The agency will now require drug companies making GLP-1 receptor agonist therapies to add safety labels warning that they could cause non-arteritic anterior ischemic optic neuropathy, or NAION.